CORRONA: 477 axSpA pts showed 25% having enthesitis (3.9 sites) at enrollment. Enthesitis pts were more likely to be female w/ nonradiographic axSpA, more likely to be Rx w/ biologic or DMARD; & Overall - had more disease activity (TJC, SJC, ASAS,BASDAI) https://t.co/weQC798mck